Goldenrod Therapeutics
Develops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathways
$6.5MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Develops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathways